Cargando…

Dynamic sensitivity analysis: Defining personalised strategies to drive brain state transitions via whole brain modelling

Traditionally, in neuroimaging, model-free analyses are used to find significant differences between brain states via signal detection theory. Depending on the a priori assumptions about the underlying data, different spatio-temporal features can be analysed. Alternatively, model-based techniques in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vohryzek, Jakub, Cabral, Joana, Castaldo, Francesca, Sanz-Perl, Yonatan, Lord, Louis-David, Fernandes, Henrique M., Litvak, Vladimir, Kringelbach, Morten L., Deco, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792354/
https://www.ncbi.nlm.nih.gov/pubmed/36582443
http://dx.doi.org/10.1016/j.csbj.2022.11.060
Descripción
Sumario:Traditionally, in neuroimaging, model-free analyses are used to find significant differences between brain states via signal detection theory. Depending on the a priori assumptions about the underlying data, different spatio-temporal features can be analysed. Alternatively, model-based techniques infer features from the data and compare significance from model parameters. However, to assess transitions from one brain state to another remains a challenge in current paradigms. Here, we introduce a “Dynamic Sensitivity Analysis” framework that quantifies transitions between brain states in terms of stimulation ability to rebalance spatio-temporal brain activity towards a target state such as healthy brain dynamics. In practice, it means building a whole-brain model fitted to the spatio-temporal description of brain dynamics, and applying systematic stimulations in-silico to assess the optimal strategy to drive brain dynamics towards a target state. Further, we show how Dynamic Sensitivity Analysis extends to various brain stimulation paradigms, ultimately contributing to improving the efficacy of personalised clinical interventions.